Riskpilot← Back to searchSign inGet full accessNATUR-DROGERIET HOLDING ApS
APSActiveCVR 58090328Nydamsvej 13-15Activities of holding companies · NACE 6421Est. 1976— employees
Revenue 2025
DKK 356K
-12% vs 2024
EBITDA margin
100.0%
-12% vs 2024
Equity ratio
64.3%
Financial strength
Net profit 2025
DKK 1,5M
+10% vs 2024
| Revenue | DKK 356K | -12% |
| EBITDA | DKK 356K | -12% |
| Net profit | DKK 1,5M | +10% |
| Total assets | DKK 22,3M | -22% |
| Equity | DKK 14,4M | -27% |
| Employees | — | — |
Legal name
NATUR-DROGERIET HOLDING ApS
CVR number
58090328
Legal form
Anpartsselskab
NACE code
6421 · Activities of holding companies
Founded
24. maj 1976
Share capital
DKK 200.000
Employees
—
VAT registered
Yes
Audit selected
Yes
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør alene
Company purpose
Selskabets formål er at besidde fast ejendom og kapitalandele i aktie- og/eller anpartsselskaber eller hermed beslægtet virksomhed.
Address
Nydamsvej 13-15
Phone
+4586923333
Email
info@natur-drogeriet.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 336 | 196 | 150 | 403 | 356 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 336 | 196 | 150 | 403 | 356 |
| Depreciation & amort. | -244 | -244 | -259 | -259 | -138 |
| EBIT | 93 | -48 | -110 | 144 | 218 |
| Net financials | 1.192 | 1.129 | 1.160 | 1.187 | 1.278 |
| Profit before tax | 1.284 | 1.081 | 1.050 | 1.331 | 1.495 |
| Tax | 10 | -46 | -68 | -4 | 24 |
| Net profit | 1.274 | 1.128 | 1.118 | 1.336 | 1.471 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 31.651 | 32.434 | 29.570 | 28.777 | 22.328 |
| Equity | 21.233 | 20.798 | 19.416 | 19.752 | 14.364 |
| Long-term debt | 6.250 | 6.152 | 6.045 | 6.443 | 6.341 |
| Short-term debt | 2.928 | 4.284 | 2.959 | 1.482 | 1.468 |
| Total debt | 9.178 | 10.436 | 9.004 | 7.925 | 7.809 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20212025
Equity ratio
64.3%
This company
38.2%
Market median
+68% vs market
20212025
Return on equity
10.2%
This company
18.4%
Market median
+45% vs market
20212025
Net profit margin
413.2%
This company
8.1%
Market median
+5001% vs market
20212025
Asset turnover
0.02×
This company
1.12×
Market median
-98% vs market
20212025
Debt / equity
0.55×
This company
0.62×
Market median
+11% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JH Management | Management | 2023 |
| Former (1) | ||
FW Audit | Audit | 1976 – 1993 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 90–99.99% | 90–99.99% | 1996 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
NATUR-DROGERIET HOLDING ApS 
J.C. EJENDOMSSELSKAB A/SBoard members of NATUR-DROGERIET HOLDING ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Finn Weck Warhuus | Audit | 0 companies |
| Jonna Harken Christiansen | Management | 0 companies |